Multiple cellular pathways and cell types

The designation "Multiple cellular pathways and cell types" is a non-specific descriptor rather than a defined molecular target. It typically refers to therapeutic agents or biological phenomena that lack a single, primary site of action, instead influencing a broad spectrum of intracellular signaling cascades and diverse histological populations. This concept is often associated with polypharmacology, where a drug's efficacy is derived from its simultaneous interaction with multiple receptors, enzymes, or transporters (Hopkins, A. L., Nature Chemical Biology, 2008). This approach is frequently employed in treating complex, multifactorial diseases like cancer or neurodegeneration, where targeting a single pathway may be insufficient due to biological redundancy (Peters, J. U., Journal of Medicinal Chemistry, 2013). However, because this designation encompasses a wide range of interactions across various tissues, it is associated with a higher risk of off-target effects and complicates the development of specific safety profiles. From a regulatory and clinical perspective, such a broad classification makes it difficult to establish clear mechanisms of action or precise biomarkers for patient selection. Consequently, this term is generally used in high-level summaries to indicate a systemic or multi-faceted biological impact that cannot be attributed to a single protein or gene product.

Other names

PolypharmacologyMulti-target activityPleiotropic effectsSystemic signalingNetwork pharmacology

Non-specific modulation of various molecular targets and signaling networks across different tissues.